Vienna BioCenter is a partner and venue for Keystone Symposia. VBC hosts at least one Keystone Symposium per year, which links scientific leaders in the covered fields to local experts and makes VBC known to thousands of international scientists. The first Keystone Symposium at VBC will take place in November 2018.

Vienna BioCenter in collaboration with Keystone Symposia will host the inaugural Keystone Symposium in Vienna from 11 to 14 November 2018. The topic will be “Rare to Care: Discovery, Modeling and Translation of Rare Diseases.”

The four-day conference is presented by Josef M. Penninger, Scientific Director of the Institute of Molecular Biotechnology (IMBA) and Kym Boycott of Canada’s CHEO Research Institute, and will take place in the IMP Lecture Hall. The conference will examine the current and future bottlenecks to gene discovery, disease modeling, and therapeutic approaches for the estimated 7,000 known rare diseases, and suggest strategies to accelerate progress in this regard.

For more information on the program, speakers and deadlines, and to submit an abstract or register, please visit www.keystonesymposia.org/18S4.

Please note that scholarships for students and postdocs are available.

Keystone Symposia on Cellular and Molecular Biology is based in Silverthorne, Colorado (USA). Founded in 1972, it convenes open, peer-reviewed conferences across a broad range of the life sciences. Keystone Symposia organized its first meeting in Europe in Cambridge (UK) in 2006 and held its first conference on rare diseases in March 2017 in Boston, Massachusetts, USA. The same year, Keystone Symposia announced that Vienna Biocenter would become a regular venue for annual symposia in Europe.

Information on future Keystone Symposia at Vienna Biocenter will be presented here shortly.

Organizer Interview: J. Penninger